Elsevier

Autonomic Neuroscience

Volume 177, Issue 2, October 2013, Pages 143-147
Autonomic Neuroscience

Cardiovascular autonomic dysfunction in non-obese diabetic mice

https://doi.org/10.1016/j.autneu.2013.03.011Get rights and content

Abstract

It is known that diabetes is associated with autonomic dysfunction; however, data about autonomic function in non-obese diabetic mice (NOD) remain scarce. We evaluated the autonomic profile of NOD mice. Female mice, 24–28 week old, were divided in two groups: NOD (n = 6) and control (n = 6, Swiss mice). NOD mice with glycemia ≥ 300 mg/dl were used. Heart rate variability (HRV) and arterial pressure variability (APV) in time and frequency domains, symbolic analysis of heart rate (HR) and baroreflex sensitivity were evaluated. HR and arterial pressure (AP) were similar between the groups; however, HRV (total variance of RR interval: NOD = 21.07 ± 3.75 vs. C = 42.02 ± 6.54 ms2) and the vagal modulation index RMSSD were lower in NOD group (4.01 ± 0.32 vs. 8.28 ± 0.97 ms). Moreover, the absolute and normalized low-frequency (LF) components were also enhanced in NOD (normalized = 61.0 ± 4.0%) as compared to control mice (normalized = 20.0 ± 4.0%). Both the absolute and normalized high-frequency (HF) components were lower in NOD (normalized = 39.0 ± 4.0%) when compared to the control group (normalized = 80.0 ± 4.0). In the symbolic analysis the 0V pattern, an indication of sympathetic activity, was higher in NOD and 2LV pattern, an indication of parasympathetic activity, was lower in the NOD than in the control group. Both bradycardic and tachycardic responses were decreased in NOD (3.01 ± 0.72 vs. 4.54 ± 0.36 bpm/mm Hg and 2.49 ± 0.31 vs. C = 3.43 ± 0.33 bpm/mm Hg) when compared to the control group. Correlation analysis showed negative correlations between vagal indexes (RMSSD, %HF and 2LV) and glycemic levels. In conclusion, NOD mice develop severe diabetes correlated with autonomic dysfunction.

Introduction

The prevalence of diabetes in modern society has been increasing at epidemic rates, largely related to the prevalence of obesity and sedentary lifestyles. Diabetes increases cardiovascular morbidity and mortality related to autonomic dysfunction, nephropathy and neuropathy (Zimmet et al., 1997).

Among these complications, autonomic neuropathy is a common alteration presented in diabetes mellitus which results in autonomic nerve fiber dystrophy in axons and dendrite abnormalities (Schmidt, 2002). In addition, cardiovascular autonomic neuropathy seems to be related to increased mortality in diabetic patients (Vinik and Ziegler, 2007). Moreover, both the parasympathetic and sympathetic neurons can be affected by diabetic neuropathy resulting in alterations of heart rate control and vascular dynamics (Schumer et al., 1998). Our group has showed several autonomic, hemodynamic and functional cardiac alterations promoted by experimental diabetes, resulting in higher mortality (Wichi et al., 2007, Mostarda et al., 2009, Jorge et al., 2012). Additionally, it is widely acknowledged that neuropathy promotes a decrease in heart rate variability (HRV) both in time and frequency domains, as demonstrated by alterations in low frequency and high frequency components. On the other hand, it is well established that HRV is an important prognostic marker of mortality (Malik et al., 1996).

Among several experimental models used to study the pathophysiology of diabetes, non-obese diabetic mice (NOD) have been widely used to evaluate several mechanisms affected by type 1diabetes. These mice exhibit spontaneous autoimmune diabetes by causing the destruction of insulin producing cells, similar to that observed in humans (Kodama et al., 2003). Furthermore, polydipsia, polyuria, glycosuria, hyperglycemia and insulin deficiency are equally observed in these animals, accompanied by a rapid weight loss (Makino et al., 1980).

Although the association of diabetes and autonomic dysfunction has been widely recognized, data on cardiovascular autonomic function in NOD mice remain scarce. Therefore, the aim of this study was to investigate the cardiovascular autonomic profile of NOD mice.

Section snippets

Experimental groups

Groups studied: (1) female hyperglycemic NOD mice (n = 6): blood glucose > 300 mg/dl (> 17 mmol/l); and (2) Swiss female mice (n = 6): used as control, blood glucose < 110 mg/dl (< 6 mmol/l).

All surgical procedures and protocols used were approved by the Nove de Julho University Ethical Committee (protocol number AN0029-2012) and strictly followed National Institutes of Health Guide for the Care and Use of Laboratory Animals.

Blood glucose level measurements

Ten-week-old female mice had their blood glucose levels determined weekly using

Cardiovascular measurements

AP (systolic, diastolic and mean) and HR were not significantly different between NOD and control groups (Table 1). The results of BRS are shown in Fig. 1. There was significant difference between baroreflex bradycardic responses evoked by phenylephrine in NOD group when compared to the control group (P = 0.036). Additionally, baroreflex tachycardic responses were significantly lower in NOD group when compared to the control group (P = 0.027).

Time and frequency domains of cardiovascular autonomic

Discussion

The main finding of the present study was that autonomic dysfunction was found in NOD mice, as demonstrated by different methods and analysis. In contrast to a previous study of the autonomic profile in NOD mice (Gross et al., 2008), we showed BRS impairment and changes in sympathetic and parasympathetic modulation. Furthermore, the autonomic alterations observed in the present study were correlated with glycemic levels. Both the increase in sympathetic activity, as well as the reduction in

Conclusions

Grounded on the methods adopted in this study and on our focus on the age and the phase of diabetes progression, we may suggest that the NOD mice present autonomic function impairment, probably related to their glycemic levels.

Competing interests

The author(s) declare that they have no competing interests.

References (34)

  • S.M. Abd El Dayem et al.

    Natural progression of cardiac autonomic neuropathy in patients with type 1 diabetes: a four-year follow-up study

    Anadolu Kardiyol. Derg.

    (2011)
  • G.E. Billman

    Cardiac autonomic neural remodeling and susceptibility to sudden cardiac death: effect of endurance exercise training

    Am. J. Physiol. Heart Circ. Physiol.

    (2009)
  • J.A. Colucci et al.

    Renin–angiotensin system may trigger kidney damage in NOD mice

    J. Renin Angiotensin Aldosterone Syst.

    (2011)
  • P. Dall'Ago et al.

    Reflex control of arterial pressure and heart rate in short-term streptozotocin diabetic rats

    Braz. J. Med. Biol. Res.

    (2002)
  • K. De Angelis et al.

    Exercise training changes autonomic cardiovascular balance in mice

    J. Appl. Physiol.

    (2004)
  • K. De Angelis et al.

    Sympathetic overactivity precedes metabolic dysfunction in a fructose model of glucose intolerance in mice

    Am. J. Physiol. Regul. Integr. Comp. Physiol.

    (2012)
  • R. Fazan et al.

    Power spectra of arterial pressure and heart rate in streptozotocin-induced diabetes in rats

    J. Hypertens.

    (1999)
  • Cited by (0)

    1

    These authors contributed equally to this work.

    View full text